LIVERSTAT is now a Notified Medical Device
We are thrilled to announce that LIVERSTAT, our software as medical device (SaMD) has been officially listed as a Class A Medical Device by the
We are ISO 13485 certified!
We are thrilled to announce that Fibronostics has achieved ISO 13485 certification, a significant milestone in our journey towards excellence in quality management systems for
Meet our team at Pri-Med South
Come meet our team at PRIMED South, this February 8-10 in Greater Ft Lauderdale, Florida! We look forward to connecting with others in the industry,
Meet our team this coming AASLD on Nov 11 to Nov 14 in Boston, MA
We’re excited to announce that Fibronostics will be attending AASLD on 11.10-11.14 in Boston, MA! We will be presenting 5 posters and can’t wait to network
Fibronostics joining forces with Stone diagnostics for Enhanced Laboratory services
We are proud to announce today of our strategic partnership with STONE Diagnostics, a leading provider of laboratory services in the United States. STONE Diagnostics will provide
Fibronostics will be at the EASL2023 congress in Vienna!
Fibronostics will be guests at the EASL congress in Vienna, Austria to present ‘NAFLD: Diagnostics and non-invasive assessment’. Join Dr. Mona Munteanu, our Chief Scientific Officer, on 24 June
